Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illumina, Inc. (ILMN) vs JPMorgan Ultra Short Income ETF (JPST) Price & Performance

Illumina, Inc.Trade
JPMorgan Ultra Short Income ETFTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs JPMorgan Ultra Short Income ETF — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while JPMorgan Ultra Short Income ETF trades at $50.45. The key difference: Illumina, Inc. is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.

ILMNJPST
Market Cap
$29.12B
Sector
HealthLeveraged / Inverse
52-Week High
$205.10$50.78
52-Week Low
$91.00$50.40
Enterprise Value
$30.48B

Returns comparison

Trailing returns across standard periods

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN

About JPMorgan Ultra Short Income ETF

JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.

Read more on JPST